Injectable Semaglutide
- Home
- Injectable Semaglutide
Compounded Semaglutide is a patient-specific medication prescribed by a licensed healthcare provider following an individualized medical evaluation. It is prepared by a licensed U.S. compounding pharmacy registered under Section 503A or by a 503B FDA-registered outsourcing facility.
Compounded medications are not reviewed or approved by the U.S. Food and Drug Administration (FDA). As such, they may differ from FDA-approved products in terms of safety, effectiveness, quality, and potential side effects. Data from clinical studies on FDA-approved medications should not be assumed to apply to compounded versions.
In addition, patients receiving compounded semaglutide are monitored by a licensed healthcare provider to help promote appropriate use and ongoing evaluation of their treatment plan. Therapy is prescribed only after a medical assessment to determine eligibility, and patients are encouraged to discuss potential risks, benefits, and alternative options with their provider to make informed healthcare decisions.
Weight Loss MD works exclusively with licensed U.S.-based compounding pharmacies that operate in accordance with applicable federal and state regulations.
